Scientists launch major effort to unravel mysteries of rare brain and spinal cord diseases

NCT ID NCT01623076

Ongoing Knowledge-focused Sponsor: University of Texas Southwestern Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 150 people with rare neuroimmunologic disorders like neuromyelitis optica and transverse myelitis. Researchers collect medical data and blood samples over time to learn what causes inflammation and why some patients respond to treatments while others do not. The goal is to improve diagnosis and treatment for these conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help researchers identify new ways to diagnose and treat rare neuroimmunologic disorders like neuromyelitis optica and transverse myelitis.
What could go wrong: This is an observational study, not a treatment trial, so it will not directly benefit participants. It may take years to yield actionable insights.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROMYELITIS OPTICA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute transverse myelitis neuromyelitis optica optic neuritis transverse myelitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEUROMYELITIS OPTICA NEUROMYELITIS OPTICA SPECTRUM DISORDER OPTIC NEURITIS TRANSVERSE MYELITIS

Contacts and locations

Locations

The University of Texas Southwestern Medical Center

Dallas, Texas, 75390, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.